Načítá se...
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients
BACKGROUND: Aspirin is the most widely studied and prescribed antiplatelet agent for preventing serious vascular events, reducing the odds of such events among high vascular risk patients by about a quarter. Thienopyridine derivatives inhibit platelet activation by a different mechanism and so may b...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2009
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7055203/ https://ncbi.nlm.nih.gov/pubmed/19821273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001246.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|